ArticleFrontiers in public health2026
Cross-sectional study on the current status of county-level cancer prevention and treatment capabilities in the four southwestern provinces of China.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A study of factors influencing access to MDT among patients with stage III to stage IV colorectal cancer: a national multicenter survey.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The grassroots regions in the four provinces of Southwest China bear a high burden of cancer nationally. In response, the Chinese government has been continuously promoting the construction of a grassroots cancer prevention and treatment system. This study aims to systematically evaluate the current capacity for cancer prevention and treatment at the county level in this region, aligning with the "Healthy China" strategy and the "Thousand-County Project" policy objectives. Methods: This cross-sectional study was conducted from December 2023 to March 2024. A standardized online questionnaire was distributed to 470 district and county (city) level hospitals across four provinces in Southwest China (Yunnan, Sichuan, Guizhou, and Guangxi). The survey investigated the availability of hardware facilities, staffing levels, and clinical practice standards related to cancer care. Descriptive statistical analysis was used to assess the current status of cancer prevention and treatment resources and capabilities. Comparisons between groups for categorical variables were performed using the chi-square test, while continuous variables were compared using the Results: Tertiary hospitals dominate county-level cancer prevention and control in the four southwestern provinces (63.6%), and 46.1% of cancer prevention and control hospitals have established cancer prevention and control centers. Imaging examination coverage is high (CT/MRI coverage rates of 97.5/88.4%), and access to conventional cancer treatment methods is good (access rates for curative surgery, targeted therapy, chemotherapy, endocrine therapy, and immunotherapy are 79.1, 97.5, 96.4, 83.2% and 87.3%, respectively). Multidisciplinary diagnosis and treatment models are developing rapidly (MDT implementation rate of 56.8%), and pathology support is strong (77.8% of hospitals conduct pathological diagnosis). However, the configuration of radiotherapy equipment is significantly insufficient (0.16 linear accelerators per county on average); the rate of independently conducted gene testing is only 16.2%. The accessibility of analgesic drugs exceeds 80%. Conclusions: Basic clinical capabilities for cancer prevention and treatment at the county level in the four provinces of Southwest China are developing rapidly. The district and county (city) level cancer hospitals demonstrate high accessibility to conventional treatment modalities (surgery, chemotherapy, targeted therapy, immunotherapy, pain management, etc.) and imaging/pathological diagnostics. However, challenges remain in advanced areas of precision medicine, such as a significant lack of genetic testing capacity. Additionally, while the MDT model is progressing quickly, it still lags behind levels seen in developed countries. Finally, radiotherapy resources at the county level in this region are insufficient and unevenly distributed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.